Crown Media

Crown Bioscience is a global contract research organization (CRO) specializing in translational oncology and immuno-oncology drug discovery and development. The company provides a comprehensive suite of preclinical and translational services, including the world's largest commercially available collection of patient-derived xenograft (PDX) models and advanced tumor organoid platforms. By leveraging in vivo, in vitro, ex vivo, and in silico methods, Crown Bioscience enables pharmaceutical and biotechnology partners to improve the predictivity of drug efficacy and safety before clinical trials. Headquartered in San Diego, the company operates multiple facilities across the United States, Europe, and Asia-Pacific, serving over 1,100 global clients.